Pfizer   4Q Revenues: $13.6 billion (-2%) 4Q Earnings: $2.6 billion (-59%) FY Revenues: $51.6 billion (-6%) FY Earnings: $22.0 billion (+51%) Comments: Primary Care and Specialty Care revenues were $3.4 billion in the quarter, down 10% and 7%, respectively. Emerging Markets revenue was $2.7 billion, up 4%. Established Products revenue was $2.4 billion, up 2%. Consumer Healthcare sales were $943 million, up 1%. Oncology sales were up 26% to $468 million. Revenues in the quarter reflect an ope...